Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study Article Swipe

Leticia Monin , Adam G. Laing , Miguel Muñoz‐Ruiz , Duncan R. McKenzie , Irene del Molino del Barrio , Thanussuyah Alaguthurai , Clara Domingo‐Vila , Thomas S. Hayday , Carl Graham , Jeffrey Seow , Sultan Abdul-Jawad , Shraddha Kamdar , Elizabeth Harvey-Jones , Rosalind Graham , Jack Cooper , Muhammad Khan , Jennifer Vidler , Helen Kakkassery , Shubhankar Sinha , Richard Davis , Liane Dupont , Isaac Francos-Quijorna , Charlotte O’Brien-Gore , Puay Ling Lee , Josephine Eum , Maria Conde Poole , Magdalene Joseph , Daniel Davies , Yin Wu , Angela Swampillai , Bernard V. North , Ana Montes , Mark Harries , Anne Rigg , James Spicer , Michael H. Malim , Paul Fields , Piers Patten , Francesca Di Rosa , Sophie Papa , Timothy Tree , Katie J. Doores , Adrian Hayday , Sheeba Irshad · YOU? · · 2021 · Open Access · · DOI: https://doi.org/10.1016/s1470-2045(21)00213-8 · OA: W3157453497